眩晕宁治疗椎-基底动脉供血不足60例临床疗效观察

Clinical ob servation of 60 cases of vertigo vertebral-basilar artery insufficiency

目的:评价眩晕宁治疗椎-基底动脉供血不足的临床疗效。方法:2组患者在治疗开始时都予丹参酮ⅡA磺酸钠注射液300mg静滴,qd,疗程为7d,间隔3d后行第2个疗程,同时治疗组60例采用眩晕宁治疗,对照组56例采用倍他司汀片治疗,7d后分别观察2组患者临床疗效。结果:总有效率眩晕宁组为92.1%,倍他司汀对照组为76.2%,2组差异有显著性;1个月后观察2组患者血液流变学改善情况,眩晕宁组治疗后血液流变学各项指标改善明显优于对照组,差异有显著性。结论:眩晕宁治疗椎-基底动脉供血不足的疗效优于倍他司汀组,是治疗椎-基底动脉供血不足的理想药物。

OBJECTIVE To abserve the treatment of dizziness assessment of vertebral-basilar artery insufficiency with Xuanyanning tablets. METHODS In the treatment of two groups of patients tanshinone IIA sodium intravenous injection was given with 300 mga day, seven days course of treatment for an interval of 3 days after the 2nd line treatment, 60 cases of treatment group at the same timewere given with Xuanyanning tablets, control group 56 cases using betahistine tablets, respectively, was observed after 7 days. RF.SULTS The total effective rate Xuanyanning group was 92. 1%, betahistine the control group was 76. 2~, group differences were significant; 1 month later hemorrheology was observed. CONCLUSION Treatment of vertigo vertebral-basilar artery insufficiency with Xuanyanning is more effective than betahistine group.